904686

Pomalidomide-C6-PEG3-butyl azide

≥95%

Manufacturer: Sigma Aldrich

CAS Number: 2300178-66-7

Synonym(S): 6-(2-(2-((6-Azidohexyl)oxy)ethoxy)ethoxy)-N-(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)hexanamide, Crosslinker−E3 ligase ligand conjugate, Pomalidomide-6-2-2-6-N3, Protein degrader building block for PROTAC® research, Template for synthesis of targeted protein degrader

Select a Size

Pack Size SKU Availability Price
50 MG 904686-50-MG In Stock ₹ 46,168.63

904686 - 50 MG

₹ 46,168.63

In Stock

Quantity

1

Base Price: ₹ 46,168.63

GST (18%): ₹ 8,310.353

Total Price: ₹ 54,478.983

ligand

pomalidomide

Assay

≥95%

form

powder or crystals

reaction suitability

reaction type: click chemistryreagent type: ligand-linker conjugate

functional group

azide

storage temp.

2-8°C

SMILES string

O=C(C(CC1)N(C2=O)C(C3=C2C=CC=C3NC(CCCCCOCCOCCOCCCCCCN=[N+]=[N-])=O)=O)NC1=O

Related Products

Img

Sigma Aldrich

904880

≥95%...

Img

Sigma Aldrich

903434

≥95%...

Img

Sigma Aldrich

909394

≥95%...

Img

Sigma Aldrich

909386

≥95%...

Description

  • Application: Protein degrader builiding block Pomalidomide-C6-PEG3-Butyl Azide enables the synthesis of molecules for targeted protein degradation and PROTAC (proteolysis-targeting chimeras) technology. This conjugate contains a Cereblon (CRBN)-recruiting ligand, a linker with both hydrophobic and hydrophilic moieties, and a pendant azide for click chemistry with a target ligand. Because even slight alterations in ligands and crosslinkers can affect ternary complex formation between the target, E3 ligase, and PROTAC, many analogs are prepared to screen for optimal target degradation. When used with other protein degrader building blocks with a pendant azide group, parallel synthesis can be used to more quickly generate PROTAC libraries that feature variation in crosslinker length, composition, and E3 ligase ligand.
  • Other Notes: Technology Spotlight: Degrader Building Blocks for Targeted Protein DegradationPortal: Building PROTAC® Degraders for Targeted Protein DegradationTargeted Protein Degradation by Small MoleculesSmall-Molecule PROTACS: New Approaches to Protein DegradationTargeted Protein Degradation: from Chemical Biology to Drug DiscoveryImpact of linker length on the activity of PROTACs
  • Legal Information: PROTAC is a registered trademark of Arvinas Operations, Inc., and is used under license

SAFETY INFORMATION

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Compare Similar Items

Show Difference

Img

Sigma Aldrich

904686

≥95%...


ligand:
pomalidomide

Assay:
≥95%

form:
powder or crystals

reaction suitability:
reaction type: click chemistryreagent type: ligand-linker conjugate

functional group:
azide

storage temp.:
2-8°C

SMILES string:
O=C(C(CC1)N(C2=O)C(C3=C2C=CC=C3NC(CCCCCOCCOCCOCCCCCCN=[N+]=[N-])=O)=O)NC1=O

Img

Sigma Aldrich

904694

≥95%...


ligand:
__

Assay:
≥95%

form:
powder or crystals

reaction suitability:
core: iridiumreagent type: catalystreaction type: Photocatalysis

functional group:
__

storage temp.:
__

SMILES string:
__

Img

Sigma Aldrich

904708

≥95%...


ligand:
pomalidomide

Assay:
≥95%

form:
powder or crystals

reaction suitability:
reactivity: sulfuryl reactivereagent type: ligand-linker conjugate

functional group:
alkyl halide

storage temp.:
2-8°C

SMILES string:
ICCCCCCOCCOCCOCCCCCC(NC1=CC=CC2=C1C(N(C3CCC(NC3=O)=O)C2=O)=O)=O

Img

Sigma Aldrich

904716

--


ligand:
__

Assay:
__

form:
powder or crystals

reaction suitability:
__

functional group:
__

storage temp.:
−20°C

SMILES string:
__